Functional Nutrition as Integrated Intervention for In- and Outpatient with Schizophrenia

Curr Neuropharmacol. 2023;21(12):2409-2423. doi: 10.2174/1570159X21666230322160259.

Abstract

Schizophrenia is a chronic and progressive disorder characterized by cognitive, emotional, and behavioral abnormalities associated with neuronal development and synaptic plasticity alterations. Genetic and epigenetic abnormalities in cortical parvalbumin-positive GABAergic interneurons and consequent alterations in glutamate-mediated excitatory neurotransmission during early neurodevelopment underlie schizophrenia manifestation and progression. Also, epigenetic alterations during pregnancy or early phases of postnatal life are associated with schizophrenia vulnerability and inflammatory processes, which are at the basis of brain pathology and a higher risk of comorbidities, including cardiovascular diseases and metabolic syndrome. In addition, schizophrenia patients adopt an unhealthy lifestyle and poor nutrition, leading to premature death. Here, I explored the role of functional nutrition as an integrated intervention for the long-term management of patients with schizophrenia. Several natural bioactive compounds in plant-based whole foods, including flavonoids, phytonutrients, vitamins, fatty acids, and minerals, modulate brain functioning by targeting neuroinflammation and improving cognitive decline. Although further clinical studies are needed, a functional diet rich in natural bioactive compounds might be effective in synergism with standard treatments to improve schizophrenia symptoms and reduce the risk of comorbidities.

Keywords: Schizophrenia; bioactive compounds; functional foods; neuroinflammation; nutrition; synaptic plasticity.

MeSH terms

  • Cognitive Dysfunction* / metabolism
  • Female
  • Humans
  • Interneurons / metabolism
  • Interneurons / pathology
  • Outpatients
  • Pregnancy
  • Schizophrenia* / metabolism
  • Synaptic Transmission